• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA COLLECT SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA COLLECT SET Back to Search Results
Catalog Number 12120
Device Problems Clumping in Device or Device Ingredient (1095); Increase in Pressure (1491); Obstruction of Flow (2423); Human-Device Interface Problem (2949)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 08/13/2018
Event Type  malfunction  
Manufacturer Narrative
Investigation: the run data file was analyzed for this event.The signals in the d log along with the images indicate clumping during the run was likely the root cause for the multiple¿return pressure was too high¿ alarms.Images show signs of clumping around the same time the system began to receive the pressure alarms.This indicates that clumping was likely the cause of the alarms.The system received the, ¿high-level reservoir sensor detected excess fluid¿ alarm which occurs if the high reservoir level sensor sees fluid earlier than expected.This can typically occur if there is foaming in the reservoir, clumping in the reservoir, if the collect line is obstructed among other reasons.Clumping in the reservoir is likely the culprit for this procedure.The likelihood for platelet clumping to occur during a run is difficult to predict since it is not dependent on aspecific platelet count and varies by patient.Therefore, every procedure should be observed for clumping in the connector and the collect port.If a clump is observed in this location, it is best to eliminate it and stop the clotting cascade as quickly as possible by reducing the inlet: ac ratio to 8.The inlet: ac ratio was only decreased at the end of the procedure.As such, the clotting cascade had been activated and the clumping was likely more difficult to reverse.Consequently, it may have helped to use a lower inlet: ac ratio from the beginning of the procedure, and to reduce the inlet: ac ratio to 8 at the first signs of clumping.Investigation is in process.A follow up report will be provided.
 
Event Description
The customer reported that the device had return pressure high alarms during a spectra optiia mononuclear cell(mnc) collection procedure.The nurse observed clotting in several places in the disposable set, including the return line.The patient was disconnected and a second collection occurred the following day.Per the customer, no injury occurred to the patient.Patient identifier and date of birth are not available at this time.Patient gender and weight were obtained from the run data file (rdf).The optia collection set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
This report is being filed to provide additional information.Investigation: a review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.Root cause: signals in the dlog along with the images indicate that it is possible, though not confirmed, that clumping during the run was contributed to the multiple ¿return pressure was too high¿ alarms.Images show signs of clumping around the same time the system began to receive the pressure alarms.This indicates that clumping was likely the cause of the alarms.The system received the, ¿high-level reservoir sensor detected excess fluid¿ alarm which occurs if the high reservoir level sensor sees fluid earlier than expected.This can typically occur if there is foaming in the reservoir, clumping in the reservoir, if the collect line is obstructed among other reasons.The likelihood for platelet clumping to occur during a run is difficult to predict since it is not dependent on a specific platelet count and varies by patient.Therefore, every procedure should be observed for clumping in the connector and the collect port.If a clump is observed in this location, it is best to eliminate it and stop the clotting cascade as quickly as possible by reducing the inlet:ac ratio to 8.The inlet:ac ratio was only decreased at the end of the procedure.As such, the clotting cascade had been activated and the clumping was likely more difficult to reverse.Consequently, it may have helped to use a lower inlet:ac ratio from the beginning of the procedure, and to reduce the inlet:ac ratio to 8 at the first signs of clumping.
 
Event Description
Further follow up with the customer confirmed more details of the procedural events which included; the operator flushed the patient's ivc, it was noted to be sluggish but patent.The operator continued to receive high pressure alarms on the return line.The patient was recannulated but unable to continue the procedure.Rinseback was commenced by the registered nurse.The mononuclear cell (mnc) product was collected by the customer's stem cell lab scientist and terumo bct was informed that there were clots / thread-like deposits / fibrin clots in the product.The product was not usable and the patient would return for day 2 collection.Due to eu personal data protection laws, the patient information is not available from the customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA COLLECT SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
steve kern
10810 w collins ave
lakewood, CO 80215
3032392246
MDR Report Key7856602
MDR Text Key120109928
Report Number1722028-2018-00243
Device Sequence Number1
Product Code GKT
UDI-Device Identifier05020583121201
UDI-Public05020583121201
Combination Product (y/n)N
Reporter Country CodeGB
PMA/PMN Number
K172590
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 09/07/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/07/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/01/2020
Device Catalogue Number12120
Device Lot Number1803023230
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Manufacturer Received09/12/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/03/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Weight130
-
-